Line 32: |
Line 32: |
| *Capsular polysaccharides produced by some strains prevent phagocytosis and interfere with complement | | *Capsular polysaccharides produced by some strains prevent phagocytosis and interfere with complement |
| *Endotoxin is a lipolysaccharide component of the cell wall of Gram-negative bacteria, composed of lipid A, a core polysaccharide and various side chains | | *Endotoxin is a lipolysaccharide component of the cell wall of Gram-negative bacteria, composed of lipid A, a core polysaccharide and various side chains |
− | *'''Endotoxin''' is realeased when bacteria die, and causes endothelial damage leading to [[Thrombosis - Pathology#Disseminated Intravascular Coagulation|'''disseminated intravascular coagulation''']] and e'''ndotoxic shock'''; it is also a '''pyrogen''' | + | *'''Endotoxin''' is realeased when bacteria die, and causes endothelial damage leading to [[Disseminated Intravascular Coagulation|'''disseminated intravascular coagulation''']] and e'''ndotoxic shock'''; it is also a '''pyrogen''' |
| *Enterotoxins, verotoxins and cytotoxic necrotising factors produced by many pathogenic ''E. coli''; these produce cell damage at their site of action | | *Enterotoxins, verotoxins and cytotoxic necrotising factors produced by many pathogenic ''E. coli''; these produce cell damage at their site of action |
| *'''Alpha-haemolysin''' may increase iron availability for invading organisms | | *'''Alpha-haemolysin''' may increase iron availability for invading organisms |
Line 161: |
Line 161: |
| **Strains do not product LT or ST and are not enteroinvasive | | **Strains do not product LT or ST and are not enteroinvasive |
| **Attaching and effacing lesions, unrelated to toxin production | | **Attaching and effacing lesions, unrelated to toxin production |
− | **[[Thrombosis - Pathology#Disseminated Intravascular Coagulation|Disseminated intravascular coagulation]] and thrombus formation | + | **[[Disseminated Intravascular Coagulation|Disseminated intravascular coagulation]] and thrombus formation |
| **''E. coli'' O157:H7 causes haemorrhagic collitis-haemolytic uraemic syndrome in humans | | **''E. coli'' O157:H7 causes haemorrhagic collitis-haemolytic uraemic syndrome in humans |
| | | |